Płatek T - Search Results

1

Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects.

Płatek T, Polus A, Góralska J, Raźny U, Dziewońska A, Micek A, Dembińska-Kieć A, Solnica B, Malczewska-Malec M. Płatek T, et al. Genes (Basel). 2021 Feb 21;12(2):307. doi: 10.3390/genes12020307. Genes (Basel). 2021. PMID: 33670024 Free PMC article.

2

Case report of dysregulation of primary bile acid synthesis in a family with X-linked adrenoleukodystrophy.

Płatek T, Orso E, Zapała B, Polus A, Kieć-Wilk B, Piwowar M, Chojnacka M, Ciałowicz U, Malczewska-Malec M, Schmitz G, Solnica B, Dembińska-Kieć A. Płatek T, et al. Medicine (Baltimore). 2018 Dec;97(49):e13353. doi: 10.1097/MD.0000000000013353. Medicine (Baltimore). 2018. PMID: 30544401 Free PMC article.

3

DNA methylation microarrays identify epigenetically regulated lipid related genes in obese patients with hypercholesterolemia.

Płatek T, Polus A, Góralska J, Raźny U, Gruca A, Kieć-Wilk B, Zabielski P, Kapusta M, Słowińska-Solnica K, Solnica B, Malczewska-Malec M, Dembińska-Kieć A. Płatek T, et al. Mol Med. 2020 Oct 7;26(1):93. doi: 10.1186/s10020-020-00220-z. Mol Med. 2020. PMID: 33028190 Free PMC article.

4

Analysis of tafazzin and deoxyribonuclease 1 like 1 transcripts and X chromosome sequencing in the evaluation of the effect of mosaicism in the TAZ gene on phenotypes in a family affected by Barth syndrome.

Płatek T, Sordyl M, Polus A, Olszanecka A, Kroczka S, Solnica B. Płatek T, et al. Mutat Res. 2023 Jan-Jun;826:111812. doi: 10.1016/j.mrfmmm.2022.111812. Epub 2022 Dec 29. Mutat Res. 2023. PMID: 36628843 Free article.

5

A novel TAZ gene mutation and mosaicism in a Polish family with Barth syndrome.

Zapała B, Płatek T, Wybrańska I. Zapała B, et al. Among authors: platek t. Ann Hum Genet. 2015 May;79(3):218-24. doi: 10.1111/ahg.12108. Epub 2015 Mar 16. Ann Hum Genet. 2015. PMID: 25776009 Free PMC article.

6

Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young.

Szopa M, Ludwig-Gałęzowska A, Radkowski P, Skupień J, Zapała B, Płatek T, Klupa T, Kieć-Wilk B, Borowiec M, Młynarski W, Wołkow P, Małecki MT. Szopa M, et al. Among authors: platek t. Pol Arch Med Wewn. 2015;125(11):845-51. doi: 10.20452/pamw.3164. Epub 2015 Nov 9. Pol Arch Med Wewn. 2015. PMID: 26552609 Free article.

7

A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.

Hohendorff J, Szopa M, Skupien J, Kapusta M, Zapala B, Platek T, Mrozinska S, Parpan T, Glodzik W, Ludwig-Galezowska A, Kiec-Wilk B, Klupa T, Malecki MT. Hohendorff J, et al. Among authors: platek t. Endocrine. 2017 Aug;57(2):272-279. doi: 10.1007/s12020-017-1341-2. Epub 2017 Jun 7. Endocrine. 2017. PMID: 28593615 Free PMC article.

8

Quality of life assessment in patients with HNF1A-MODY and GCK-MODY.

Szopa M, Matejko B, Ucieklak D, Uchman A, Hohendorff J, Mrozińska S, Głodzik W, Zapała B, Płatek T, Solecka I, Sani CM, Małecki MT. Szopa M, et al. Among authors: platek t. Endocrine. 2019 May;64(2):246-253. doi: 10.1007/s12020-018-1812-0. Epub 2018 Nov 12. Endocrine. 2019. PMID: 30421137 Free PMC article.

9

A prospective evaluation of cimetidine drug use.

Kowalsky SF, Andritz MB, Hamilton RA, Platek TE. Kowalsky SF, et al. Among authors: platek te. Hosp Pharm. 1989 Feb;24(2):105-8. Hosp Pharm. 1989. PMID: 10292189

10

Macro-monitoring: a step toward rational psychopharmacotherapy.

Chien C, Solomon K, Platek TE. Chien C, et al. Among authors: platek te. Am J Hosp Pharm. 1978 Apr;35(4):397-402. Am J Hosp Pharm. 1978. PMID: 645711

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page